Company

Our timeline.

From a decade of university research to a completed FDA Pre-Submission.

2023

Alsteni Medical founded

Incorporated to commercialize a decade of university-funded research (Coulter Foundation, NSF I-Corps)

2024

U.S. Patent 10,744,070 issued

Core device and anchor system patent issued; active pipeline of additional filings in prosecution

2025

USC Techstars graduation

Accelerator validation, commercial mentorship, investor network

CTO hired (Todd Oda, 51 patents)

Production-grade device development initiated

COO hired (Arieh Halpern, $1.5B+ commercialized)

Commercial and operational infrastructure

FDA Pre-Submission (Q252869)

510(k) pathway defined; study scope characterized as limited

PCT international patent application filed

International IP protection initiated

2026

Contract manufacturing Phase 1 complete

Prototype tube fabrication and design verification

Reimbursement strategy validated

CPT codes identified; no new coding required at launch

Clinical study academic lead confirmed

Clinical trial infrastructure in place at academic medical center

Capital raised to date: ~$565K (Techstars, Coulter Foundation, NSF I-Corps, founder investment)